Theromics
West Bridgewater
About Theromics
Theromics is the developer of a tool to address the unmet medical need to create more effective ablation zones during image-guided thermal ablation of soft tissue. Their HeatSYNC TA is used during microwave and radiofrequency ablations of cancerous tumors. Their heatSYNCTM Gel is a novel biopolymer thermal accelerant that amplifies the movement of heat energy in soft tissue and bone. The gel is made from a naturally occurring protein and delivered via a syringe, laparoscope, or bronchoscope.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.7M
- Funding stage: Seed
- Last round: Grant (May 2025)
- Website: theromicsinc.com
- Phone: 781-886-1960
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/theromics-41490 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.